Provided by Tiger Trade Technology Pte. Ltd.

Anaptysbio Inc

58.44
+0.70001.21%
Post-market: 57.51-0.9300-1.59%16:16 EDT
Volume:627.03K
Turnover:36.45M
Market Cap:1.73B
PE:-64.60
High:59.07
Open:56.96
Low:55.57
Close:57.74
52wk High:73.30
52wk Low:17.11
Shares:29.61M
Float Shares:21.05M
Volume Ratio:2.11
T/O Rate:2.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9047
EPS(LYR):-0.4601
ROE:-114.55%
ROA:6.78%
PB:135.74
PE(LYR):-127.01

Loading ...

U.S. Earnings Preview: After Market Close Aug. 18

Dow Jones
·
Aug 19

Top News Today: Stocks Fall, Oil Rises as US-Iran Tensions Mount

Dow Jones
·
Aug 18

AnaptysBio Menggelar Rapat Tahunan Pemegang Saham

Reuters
·
Aug 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 07

AnaptysBio-Tesaro Trial Heads to Post-trial Briefs, Argument Set for Oct. 20

Reuters
·
Jul 31

Analysts Offer Insights on Healthcare Companies: Community Health (CYH), AnaptysBio (ANAB) and Repligen (RGEN)

TIPRANKS
·
Jul 23

Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX), UnitedHealth (UNH) and AnaptysBio (ANAB)

TIPRANKS
·
Jul 22

Is AnaptysBio (ANAB) Undervalued Following Its Jemperli Royalty Appeal And GSK Trial?

Simply Wall St.
·
Jul 15

AnaptysBio falls -10.8%

TIPRANKS
·
Jul 15

Barclays Keeps Their Buy Rating on AnaptysBio (ANAB)

TIPRANKS
·
Jul 14

TD Cowen Remains a Buy on AnaptysBio (ANAB)

TIPRANKS
·
Jul 13

Should AnaptysBio’s (ANAB) Russell Index Removal Prompt a Rethink of Its Liquidity and Investor Base?

Simply Wall St.
·
Jul 08

Analysts Are Bullish on Top Healthcare Stocks: MindWalk Holdings (HYFT), AnaptysBio (ANAB)

TIPRANKS
·
Jul 01

Is AnaptysBio’s (ANAB) Index Exit and Office Sublease Quietly Reframing Its Strategic Focus?

Simply Wall St.
·
Jun 30

Anaptysbio Announces Annual Shareholder Meeting

Reuters
·
Jun 30

First Tracks Biotherapeutics subleases 45,057 sq ft San Diego space from AnaptysBio

Reuters
·
Jun 23

AnaptysBio (ANAB) Stock Could Be 84% Below Fair Value After Choppy Trading

Simply Wall St.
·
Jun 18

AnaptysBio Inc : H.c. Wainwright Assumes Coverage With Buy Rating; Price Target $95

THOMSON REUTERS
·
Jun 10

AnaptysBio Coverage Assumed by HC Wainwright & Co. at Buy

Dow Jones
·
Jun 10

AnaptysBio assumed with a Buy at H.C. Wainwright

TIPRANKS
·
Jun 10